What This Doctor Does to Treat Breast Cancer Differently

Interviewer: Doctor, breast cancer is one of the most talked about forms of cancer. You talk about beating that and still maintaining your health. Can you talk a little bit more about how that can be done?

Dr. Isaac Eliaz: Breast cancer and prostate cancer are an epidemic. When we focus on breast cancer we're making some progress, but not a lot of progress in conventional oncology. I think what's happening with breast cancer is a good intro into what's happening in the cancer field on its own.

We really have to understand as much as we can about the biology of the specific breast cancer. It's a field that is really growing and expanding as we talk. I mean, I'll give an example. Right now I am working with a certain breast cancer patient who is just about to start therapy. We have tissues just from the core biopsies. We can send them to a test site called Target now, which carries Target Now. This gives us some information about sensitivity to chemotherapy, but it's more based on the genome, on the genes. We can send it to Germany where they can run it through hundreds of genes. If we had tissue we can culture live tissue and at least see which chemotherapy is going to affect it in a more accurate way.

All of these things are happening right now. We still don't know which of them is more reliable or less reliable. This whole field, which oncology is still coming to, which is, 'let's understand the individual tumor'. Lobular breast cancer behaves different than ductal breast cancer. But then there's another half, more than half, which is the person. We've got to understand the person. The person, when we're talking about medication - if we understand the mind of the person, if we understand the emotion and the psychology of the person, if we understand the physiology of the person - then we have a much more individualized understanding of the person as a whole. Then we match it with the treatment and the biology of the tumor. This is how we can really make a difference. 

There's always a dance between the health of the person and between getting rid of the cancer. When the cancer is ahead, it's okay if the person doesn't feel great. We've got to stop the cancer. When the cancer gets better it's time to change strategy and start working on the person. When you have this active, dynamic understanding you get better results. It's interesting for me in this conference where we now are talking, it's really the first time in years that I have started a lecture without talking about these philosophical principles because there's so much research I wanted to share. 

I find the doctors, they skip this philosophy. I spent tens of years, hours and hours of meditation and contemplation, and reading on this very basic philosophical principle. I feel this is what allows me in my journey of healing myself, and others, to use very simple tools and to get very powerful results. Breast cancer is a good example of it.

Interviewer: When you talk about each cancer being a little bit different, let's go back to hyperthermia. Can that method be effective no matter what kind of cancer somebody has?

Dr. Eliaz: No. It has a generalized benefit because cancer, in general, is sensitive to it. But definitely, you're right, it will make a difference in which cancer we are dealing with. For example, if we have a cancer that is highly glucolytic, it really has a very strong Warburg effect. It produces a lot of lactic acid. Well, if I can stimulate this cancer furthermore by giving them glucose while I do the hyperthermia and then put them under oxidative stress, I will kill the cancer better. If this cancer is surviving more on ketone bodies or on glutamines, like ketoglutarate in the krebs cycle, I may give them other blockers while I do the heat. 

I will pick a certain chemotherapy not only based on the sensitivity of the tissue, but on the metabolism and the effect of the chemo on the metabolism. It's a whole new door. It's a whole new door that is being refined and I think I'm making some contribution to this field which makes me happy.